DAL International Ltd. Acquires a Suite of Assets That Will Give It a Foothold in the Multi-Billion Dollar International Medical Travel and Weight Loss Industry
Posted on: Tuesday, 7 August 2007, 18:11 CDT
DAL International Ltd. (PINKSHEETS: DALN) announces it has acquired the following assets; Medical Travel International, Medical Doctors International, Hospital International, Balloon Weight Loss and AltiCard from DAL Group Ltd., a private Nevada corporation.
The purpose of this acquisition was to provide DAL International a platform from which to launch its business model to become a major player in the multi-billion dollar medical travel and weight loss industry.
CEO, Dr. D. A. Leatherman, said the following, "This acquisition in conjunction with the expertise of our executive team and key consultants can position our company to win market share within the medical travel and weight loss industry. It provides our clients access to the best global medical technologies and premier medical networks of world-class physicians, surgeons and medical facilities around the world. This translates into cutting edge healthcare at truly affordable prices."
About DAL International
DAL International Ltd. is traded under the ticker symbol OTCPK: DALN and is headquarted in Las Vegas, Nevada. DAL's mission is to become a leader within the medical travel and weight loss industry. This will be done by enhancing each client's quality of life through the combined use of medical expertise that delivers specialized, state-of-the-art, world class and affordable medical care and expanded treatment options through a Premier International network of physicians and hospitals that unite across national borders.
This press release contains forward-looking statements, which are made pursuant to the Safe Harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different. Factors include, but are not limited to, available funding, market acceptance, competition, recruitment and retention of personnel, dependence on key personnel and certain risks associated with the projects in which the Company is engaged to complete and others. The forward-looking statements should be considered in light of these risks and uncertainties. The Company disavows any obligation to update or correct any of its forward-looking statements.
For more information visit us online at www.DALLTD.com.
D. A. Leatherman, D.C. Phone: 1-800-501-0024 Fax: 1-760-328-5340 eMail:DAL2@Dalltd.com
SOURCE: DAL International Ltd.
Source: MARKET WIRE
Related Articles
- Liberty Diversified Holdings, Inc. Announces Plans to Assume Control of All Website Sales of Serotrim(R) Weight Loss Drink and the Serotonin Weight Loss Diet
- DOBI Medical International Highlights New Management Appointments; Company Names Vice Chairman of Operations and Interim CEO
- DOBI Medical International to Exhibit ComfortScan(R) System at the 2006 JPR Conference
- DOBI Medical International Reports 2005 Year-End Results
- DOBI Medical International Progresses With ComfortScan(R) PMA Clinical Trial
- DOBI Medical International to Present at the NYSSA Medical Services Conference
- DOBI Medical International Announces Fall 2005 Scientific and Investment Conference Participation Schedule
- DOBI Medical International Receives ISO 13485:2003 Certification and Renews Canadian Quality System Certifications
- DOBI Medical International Progresses With ComfortScan(TM) Clinical Trial
- DOBI Medical International to Present at CEUT Emerging Growth Opportunities Conference
User Comments (0)

RSS Feeds